Moeremans, Karen; Annemans, Lieven; Lothgren, Mickael … - In: PharmacoEconomics 28 (2010) S1, pp. 107-128
Background: Two phase II trials (POWER 1 and 2) have demonstrated that darunavir co-administered with low-dose ritonavir (DRV/r) provides significant clinical benefit compared with control protease inhibitors (PIs) in highly treatment-experienced, HIV-1-infected adults, when co-administered with...